Ozempic & GLP-1 Vision Loss Lawsuits Attorneys & Lawyers in DE

Ozempic and GLP-1 Drugs Linked to Serious Eye Conditions

GLP-1 receptor agonists, including Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, Zepbound, Victoza, or Saxenda, are among the fastest-growing medications in the United States today. Millions of people take them for type 2 diabetes or weight loss. Sadly, they have also been associated with severe side effects, including permanent vision loss caused by damage to the optic nerve.

A landmark 2024 study published in JAMA Ophthalmology found that people taking semaglutide were substantially more likely to develop Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) — a sudden and often irreversible loss of vision caused by interrupted blood flow to the optic nerve, sometimes called an “eye stroke.”

The manufacturers of Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, Zepbound, Victoza, and Saxenda, (GLP-1 receptor antagonists (RAs) — Novo Nordisk and Eli Lilly — did not warn patients and prescribing physicians about this risk despite evidence that they knew or should have known that use of semaglutide is associated with greater risk of vision loss.

You have a right to make informed decisions about your treatment. At Morris James, we are pursuing the drug-makers on behalf of patients who were harmed.

Compensation Available in GLP-1 Vision Loss Lawsuits

If your vision loss is connected to a GLP-1 Drug like, Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, Victoza, Saxenda, or Zepbound, you may be entitled to compensation for past and future losses:

Past and future medical expenses, including eye care, surgery, and assistive devices
Lost wages and reduced earning capacity due to vision impairment
Pain, suffering, and emotional distress
Loss of independence, quality of life, and daily function
Home modifications or long-term care costs related to vision disability

Legal deadlines for drug injury claims — called statutes of limitations — vary by state but typically range from 1 to 3 years from the date of injury or the date you knew your vision loss was associated with your GLP-1 medication. Once that window closes, you may permanently lose your right to file. Contact us as soon as possible to protect your right to compensation.

Why Choose Our GLP-1 Vision Loss Lawyers

Pharmaceutical companies have vast legal resources and will fight hard to minimize or deny your claim. You need a GLP-1 vision loss lawyer with the experience and proven track record to take them on and win.

Our firm has handled mass torts and product liability cases against major drug manufacturers, and we know how to build the evidence-backed claims that get results.

We are accepting GLP-1 vision loss claims nationwide from our Delaware offices, and we handle every case on a contingency fee basis — you pay nothing unless we recover compensation for you.

Team Leaders

Keith E. Donovan

Managing Partner

Matthew R. Fogg

Partner

Ashley C. Curran

Associate

Who Qualifies for a GLP-1 Vision Loss Lawsuit?

You may have a GLP-1 vision loss claim if:

You were prescribed Ozempic, Wegovy, Mounjaro, Zepbound, Trulicity, Victoza, Saxenda, or Victoza
You developed NAION (non-arterial anterior ischemic optic neuropathy)
Your vision symptoms began during or shortly after starting or increasing your GLP-1 dosage
Your condition was diagnosed or documented by an ophthalmologist or eye care specialist

Pre-existing diabetes or prior eye conditions do not automatically disqualify you.

If you’re unsure whether or not you are eligible, reach out. Our attorneys will give you a clear, honest answer.

Ozempic & GLP-1 Vision Loss Lawsuits FAQs

The Ozempic vision loss lawsuit alleges that Novo Nordisk and Eli Lilly failed to warn patients about the risk of NAION — non-arteritic anterior ischemic optic neuropathy — a serious eye condition that causes sudden, often permanent vision loss due to loss of blood flow to the optic nerve. It seeks compensation for the GLP-1 users who were harmed as a result.

No. These are two separate categories of litigation involving the same medications. The gastroparesis or stomach paralysis lawsuits involve patients who experienced severe gastrointestinal injuries such as stomach paralysis (gastroparesis), bowel obstruction, and related complications. The vision loss lawsuits are an entirely distinct MDL (Multi-District Litigation) focused exclusively on optic nerve injuries, primarily NAION.

The primary GLP-1 RA drugs involved in these cases are Ozempic, Wegovy, Mounjaro, Zepbound, Victoza, Saxenda, and Trulicity. If you took a GLP-1 medication not listed here, contact us — we will evaluate your case.

If you have been diagnosed with NAION (non-arterial anterior ischemic optic neuropathy), you may have a claim. These conditions range from serious to permanently disabling.

NAION stands for Non-Arteritic Anterior Ischemic Optic Neuropathy. It is a serious eye condition caused by a sudden loss of blood flow to the optic nerve — the nerve that carries visual signals from your eye to your brain. When the optic nerve is deprived of adequate blood supply, nerve fibers die, and the vision loss that results is typically permanent. NAION strikes without warning, often overnight, and there is currently no proven treatment to reverse the damage or restore lost sight.

NAION typically causes a sudden, painless loss of vision — often noticed upon waking. You may see a dark patch or blurred area in part of your visual field. It usually affects one eye but can affect both. If you are experiencing these symptoms, you should see a doctor as soon as possible.

Yes. Having diabetes does not disqualify you. Many GLP-1 vision loss plaintiffs are diabetic patients. The legal question is whether the GLP-1 drug caused or significantly worsened your eye condition beyond what your diabetes alone would explain. Our attorneys work with independent medical experts to evaluate causation in each individual case.

Yes. Filing deadlines (statutes of limitations) vary by state, typically ranging from 1 to 3 years from the date of injury or discovery. These deadlines are strict and missing them can permanently bar your claim. We encourage you to contact our GLP-1 vision loss lawyers as soon as possible, even if you are still gathering medical records.

Nothing upfront. Our firm handles GLP-1 and Ozempic lawsuit cases on a contingency fee basis, meaning you owe no attorneys’ fees unless we recover compensation for you. Our attorneys are happy to answer any questions about our fees during your free consultation.

Ozempic & GLP-1 Vision Loss Lawsuits